(Q33548525)

English

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Wolfgang Winkelmayer

10

object named as

Wolfgang C Winkelmayer

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

object named as

Christine M Wu

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

3

object named as

Ron Shapiro

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

7

object named as

Amit Basu

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

object named as

Jerry McCauley

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Nizar Younas

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

James Johnston

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Henkie Tan

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Heidi Schaefer

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Cynthia Smetanka

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Mark Unruh

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Statins in solid organ transplantation: is there an immunosuppressive effect?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Acute renal allograft rejections, a role for statins?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Tolerogenic immunosuppression for organ transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Simvastatin initiated early after heart transplantation: 8-year prospective experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Anti-inflammatory and immunomodulatory effects of statins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Patient survival after renal transplantation III: the effects of statins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Discontinuation rates for use of statins are high

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

28 July 2018

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Statin use is associated with prolonged survival of renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

The effects of lipid-lowering agents on acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Impact of statin treatment on 1-year functional and histologic renal allograft outcome.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Statin Use Is Associated with Improved Function and Survival of Lung Allografts

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

Discontinuation of statin therapy following an acute myocardial infarction: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

31 October 2018

Do OSCAR winners live longer than less successful peers? A reanalysis of the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

31 October 2018

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

31 October 2018

Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2855559

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-11-5

21 January 2018

A double-blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20359353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statins as a newly recognized type of immunomodulator

1 reference

https://pubmed.ncbi.nlm.nih.gov/20359353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comorbid conditions in kidney transplantation: association with graft and patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20359353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20359353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20359353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2369-11-5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-11-5

9 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33548525&oldid=2195475359"